NCT01515345View on ClinicalTrials.gov

Individualizing Dual Antiplatelet Therapy After Percutaneous Coronary Intervention - The IDEAL-PCI Registry

PHASE3CompletedINTERVENTIONAL
Enrollment

1,008

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions
Platelet InhibitionCoronary Stent Implantation
Interventions
DRUG

prasugrel or ticagrelor

prasugrel 10mg od for 12 month ticagrelor 90mg td for 12 month

DRUG

Clopidogrel

clopidogrel 75mg od for 12 month

Trial Locations (1)

1100

Kaiser Franz Josef Hospital, Vienna

All Listed Sponsors
lead

Kaiser Franz Josef Hospital

OTHER

NCT01515345 - Individualizing Dual Antiplatelet Therapy After Percutaneous Coronary Intervention - The IDEAL-PCI Registry | Biotech Hunter | Biotech Hunter